vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与WisdomTree, Inc.（WT）财务数据对比。点击上方公司名可切换其他公司
WisdomTree, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的2.0倍（$147.4M vs $75.5M），WisdomTree, Inc.同比增速更快（33.2% vs 27.7%），WisdomTree, Inc.自由现金流更多（$147.7M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 23.4%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
WisdomTree, Inc.是总部位于纽约的全球ETF（交易型开放式指数基金）及交易所交易产品发行方与资产管理机构，2006年6月推出首批ETF产品，目前是美国主流ETF供应商之一。其发行的ETF覆盖全球不同资产类别与地区市场，产品线涵盖美国及国际股票、货币、固定收益及另类投资等品类。
PBYI vs WT — 直观对比
营收规模更大
WT
是对方的2.0倍
$75.5M
营收增速更快
WT
高出5.5%
27.7%
自由现金流更多
WT
多$133.3M
$14.4M
两年增速更快
PBYI
近两年复合增速
23.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $147.4M |
| 净利润 | — | $40.0M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | 40.5% |
| 净利率 | — | 27.1% |
| 营收同比 | 27.7% | 33.2% |
| 净利润同比 | — | 46.6% |
| 每股收益（稀释后） | $0.26 | $0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIWT
| Q4 25 | $75.5M | $147.4M | ||
| Q3 25 | $54.5M | $125.6M | ||
| Q2 25 | $52.4M | $112.6M | ||
| Q1 25 | $46.0M | $108.1M | ||
| Q4 24 | $59.1M | $110.7M | ||
| Q3 24 | $80.5M | $113.2M | ||
| Q2 24 | $47.1M | $107.0M | ||
| Q1 24 | $43.8M | $96.8M |
净利润PBYIWT
| Q4 25 | — | $40.0M | ||
| Q3 25 | $8.8M | $19.7M | ||
| Q2 25 | $5.9M | $24.8M | ||
| Q1 25 | $3.0M | $24.6M | ||
| Q4 24 | — | $27.3M | ||
| Q3 24 | $20.3M | $-4.5M | ||
| Q2 24 | $-4.5M | $21.8M | ||
| Q1 24 | $-4.8M | $22.1M |
毛利率PBYIWT
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYIWT
| Q4 25 | 22.7% | 40.5% | ||
| Q3 25 | 17.6% | 36.3% | ||
| Q2 25 | 12.7% | 30.8% | ||
| Q1 25 | 8.7% | 31.6% | ||
| Q4 24 | 22.6% | 31.7% | ||
| Q3 24 | 27.4% | 36.0% | ||
| Q2 24 | -4.6% | 31.3% | ||
| Q1 24 | -5.3% | 28.9% |
净利率PBYIWT
| Q4 25 | — | 27.1% | ||
| Q3 25 | 16.2% | 15.7% | ||
| Q2 25 | 11.2% | 22.0% | ||
| Q1 25 | 6.5% | 22.8% | ||
| Q4 24 | — | 24.7% | ||
| Q3 24 | 25.2% | -4.0% | ||
| Q2 24 | -9.6% | 20.3% | ||
| Q1 24 | -11.0% | 22.8% |
每股收益（稀释后）PBYIWT
| Q4 25 | $0.26 | $0.28 | ||
| Q3 25 | $0.17 | $0.13 | ||
| Q2 25 | $0.12 | $0.17 | ||
| Q1 25 | $0.06 | $0.17 | ||
| Q4 24 | $0.40 | $0.20 | ||
| Q3 24 | $0.41 | $-0.13 | ||
| Q2 24 | $-0.09 | $0.13 | ||
| Q1 24 | $-0.10 | $0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | — |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $413.7M |
| 总资产 | $216.3M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIWT
| Q4 25 | $97.5M | — | ||
| Q3 25 | $94.4M | — | ||
| Q2 25 | $96.0M | — | ||
| Q1 25 | $93.2M | — | ||
| Q4 24 | $101.0M | — | ||
| Q3 24 | $96.7M | — | ||
| Q2 24 | $96.8M | $132.5M | ||
| Q1 24 | $107.2M | $116.9M |
总债务PBYIWT
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIWT
| Q4 25 | $130.3M | $413.7M | ||
| Q3 25 | $115.3M | $373.4M | ||
| Q2 25 | $104.7M | $445.1M | ||
| Q1 25 | $97.1M | $415.6M | ||
| Q4 24 | $92.1M | $400.0M | ||
| Q3 24 | $71.1M | $374.9M | ||
| Q2 24 | $48.5M | $445.6M | ||
| Q1 24 | $51.0M | $423.2M |
总资产PBYIWT
| Q4 25 | $216.3M | $1.5B | ||
| Q3 25 | $202.9M | $1.4B | ||
| Q2 25 | $194.9M | $1.1B | ||
| Q1 25 | $196.2M | $1.0B | ||
| Q4 24 | $213.3M | $1.0B | ||
| Q3 24 | $220.7M | $1.0B | ||
| Q2 24 | $205.0M | $964.1M | ||
| Q1 24 | $214.1M | $931.7M |
负债/权益比PBYIWT
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $147.9M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $147.7M |
| 自由现金流率自由现金流/营收 | 19.1% | 100.2% |
| 资本支出强度资本支出/营收 | 0.0% | 0.1% |
| 现金转化率经营现金流/净利润 | — | 3.70× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $240.8M |
8季度趋势，按日历期对齐
经营现金流PBYIWT
| Q4 25 | $14.4M | $147.9M | ||
| Q3 25 | $9.7M | $48.1M | ||
| Q2 25 | $14.1M | $38.8M | ||
| Q1 25 | $3.6M | $6.4M | ||
| Q4 24 | $15.6M | $113.5M | ||
| Q3 24 | $11.0M | $47.7M | ||
| Q2 24 | $1.0M | $32.2M | ||
| Q1 24 | $11.2M | $-1.0M |
自由现金流PBYIWT
| Q4 25 | $14.4M | $147.7M | ||
| Q3 25 | $9.7M | $48.0M | ||
| Q2 25 | $14.1M | $38.7M | ||
| Q1 25 | $3.6M | $6.3M | ||
| Q4 24 | $15.6M | $113.3M | ||
| Q3 24 | $11.0M | $47.7M | ||
| Q2 24 | $1.0M | $32.2M | ||
| Q1 24 | — | $-1.1M |
自由现金流率PBYIWT
| Q4 25 | 19.1% | 100.2% | ||
| Q3 25 | 17.7% | 38.2% | ||
| Q2 25 | 26.8% | 34.4% | ||
| Q1 25 | 7.7% | 5.9% | ||
| Q4 24 | 26.4% | 102.4% | ||
| Q3 24 | 13.7% | 42.1% | ||
| Q2 24 | 2.1% | 30.1% | ||
| Q1 24 | — | -1.1% |
资本支出强度PBYIWT
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | 0.1% | ||
| Q1 25 | 0.1% | 0.0% | ||
| Q4 24 | 0.0% | 0.1% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.0% | 0.1% |
现金转化率PBYIWT
| Q4 25 | — | 3.70× | ||
| Q3 25 | 1.10× | 2.44× | ||
| Q2 25 | 2.41× | 1.57× | ||
| Q1 25 | 1.21× | 0.26× | ||
| Q4 24 | — | 4.15× | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | 1.48× | ||
| Q1 24 | — | -0.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
WT
| Investment Advisory Management And Administrative Service | $122.7M | 83% |
| Other Services Income | $12.7M | 9% |
| IE | $11.5M | 8% |
